What is NewLimit's current valuation?

NewLimit's valuation has tripled to $3.1 billion.

Who are the investors in the longevity sector?

Investors include Jeff Bezos and NVIDIA, among other billionaires, according to the report.

Jeff Bezos and NVIDIA Back Longevity Industry

Jeff Bezos and NVIDIA are quietly backing the AI-driven longevity industry, as NewLimit's valuation triples to $3.1 billion.

June 3, 2026

2 min read

Source: 24/7 Wall St.

Key Numbers

NewLimit valuation

3.1B

In a notable shift, major capital allocators like Jeff Bezos and NVIDIA are moving into a new breakthrough industry: AI-driven biology and longevity. According to a report from 24/7 Wall St., Brian Armstrong's longevity startup NewLimit has tripled in value to $3.1 billion.

Details

A Polymarket post on X sparked a viral thread from podcast host Mgoes, cataloging billionaire investments in longevity. The exact amounts invested by Bezos and NVIDIA have not been disclosed.

Context

This comes amid a biotech boom fueled by AI, with companies like Eli Lilly (LLY) using similar technologies for drug development. However, longevity investing is bolder, focusing on extending human lifespan rather than just curing diseases.

What It Means for Investors

This trend signals a shift in venture capital towards long-term impact. Stocks like Amazon (AMZN) and Eli Lilly (LLY) may play a role, but investors should watch closely given high risks and uncertainty.

Frequently Asked Questions

NewLimit is a longevity startup founded by Coinbase founder Brian Armstrong, focusing on extending human lifespan using AI.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.